Head-to-head · Cost-Efficiency Index
Nex Gen Health Rx vs MEDVi
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Nex Gen Health Rx
Shoppers who want a named pharmacy and an itemized checkout, and who will read the homepage figure as the annual prepay it is.
Visit Nex Gen Health RxMEDVi
Shoppers who want compounded semaglutide with no contract and are budgeting on the $299 refill price, not the first-month sale price.
Visit MEDViThe verdict
Nex Gen Health Rx and MEDVi tie on the Cost-Efficiency Index at 62/100, so neither wins outright on the numbers, so choose on fit. Nex Gen Health Rx: Shoppers who want a named pharmacy and an itemized checkout, and who will read the homepage figure as the annual prepay it is. MEDVi: Shoppers who want compounded semaglutide with no contract and are budgeting on the $299 refill price, not the first-month sale price.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs Nex Gen Health Rx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Nex Gen Health Rx | MEDVi |
|---|---|---|
| Cost-Efficiency Index | 62/100 | 62/100 |
| Semaglutide / mo | $190Per 30-day supply month-to-month (the homepage's $99 is the 360-day prepay rate) | $299/moMonth-to-month refill price; first month $179, compounded |
| Tirzepatide / mo | $239Per 30-day supply month-to-month (the homepage's $149 is the 360-day prepay rate) | Not disclosed |
| Semaglutide / yr (modeled) | $2,280 | $3,588 |
| Tirzepatide / yr (modeled) | $2,868 | — |
| Coverage | Coverage not published | Not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #265 | #268 |
Nex Gen Health Rx
62/100Where the value is
- Names its pharmacy, Manifest Pharmacy, with a street address, and states the 503A class on the product pages
- The checkout itemizes what the price already covers, showing doctor support and monitoring at $99 and overnight shipping at $40 both marked free
- Full 30-, 90-, 180- and 360-day price ladders for both molecules are shown on the product page, and checkout charges the same total
The tradeoffs
- The homepage prints "for as low as $99.00 a month" and "$149.00 a month" with no basis stated; the basis appears only on a separate landing page, and it is a twelve-month plan paid in full
- That landing page sells $99 as "every month", "fixed price" and "price never increases" while its own fine print makes it conditional on $1,188 paid upfront
MEDVi
62/100Where the value is
- The FAQ states both numbers plainly: $179 for the first month and refills locked in at $299, covering the provider review, the medication and shipping
- No contract; you can cancel at any time by email or through the patient portal chat
- Names its partner pharmacies (Triad Rx, RedRock Pharmacy and Beaker Pharmacy & Compounding) and the medical groups behind its providers
The tradeoffs
- The $179 headline is a first-month "FALL Sale" price; every refill after that is $299
- Cancellation must reach support at least 72 hours before your next billing date, and monthly charges are never refunded once the month has started
Regulatory note: the FDA issued a warning letter to MEDVi, LLC dba MEDVi in February 2026. We still list and link to MEDVi; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.